Alnylam Pharmace Dl 0001 (DUL)
TG
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current DUL market cap is 30.67B. The company's latest EPS is USD -2.1486 and P/E is -115.68.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 492.85M | 844.29M | 1.04B | 1.83B | 2.25B |
| Operating Income | -828.44M | -708.65M | -785.07M | -282.18M | -176.89M |
| Net Income | -858.28M | -852.82M | -1.13B | -440.24M | -278.16M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 3.41B | 3.64B | 3.55B | 3.83B | 4.24B |
| Total Liabilities | 2.39B | 3.06B | 3.7B | 4.05B | 4.17B |
| Total Equity | 1.02B | 588.2M | -158.22M | -220.64M | 67.09M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -614.96M | -641.69M | -541.27M | 104.16M | -8.31M |
| Investing | -435.52M | -273.3M | 169.35M | -336.35M | -116.84M |
| Financing | 994.98M | 1.25B | 425.75M | 172.13M | 294.16M |
| Market Cap | 30.67B |
| Price to Earnings Ratio | -115.68 |
| Price to Sales Ratio | 14.31 |
| Price to Cash Ratio | 33.29 |
| Price to Book Ratio | 479.6 |
| Dividend Yield | - |
| Shares Outstanding | 129.46M |
| Average Volume (1 week) | 29 |
| Average Volume (1 Month) | 26 |
| 52 Week Change | 62.04% |
| 52 Week High | 280.00 |
| 52 Week Low | 132.00 |
| Spread (Intraday) | 1.1 (0.47%) |
| Company Name | Alnylam Pharmace Dl 0001 |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.alnylam.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
